awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35833312-0D252417-1DD4-4A82-95A3-1EA081050DF9
Q35833312-0D252417-1DD4-4A82-95A3-1EA081050DF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35833312-0D252417-1DD4-4A82-95A3-1EA081050DF9
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
P2860
Q35833312-0D252417-1DD4-4A82-95A3-1EA081050DF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35833312-0D252417-1DD4-4A82-95A3-1EA081050DF9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d921bba0244da49e8c9348c0ff11b0194b7ae14
P2860
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.